Literature DB >> 23179187

Hypoxia-mediated regulation of macrophage functions in pathophysiology.

Elena Riboldi1, Chiara Porta, Sara Morlacchi, Antonella Viola, Alberto Mantovani, Antonio Sica.   

Abstract

Oxygen availability affects cell differentiation, survival and function, with profound consequences on tissue homeostasis, inflammation and immunity. A gradient of oxygen levels is present in most organs of the body as well as in virtually every site of inflammation, damaged or pathological tissue. As a consequence, infiltrating leukocytes, macrophages in particular, are equipped with the capacity to shift their metabolism to anaerobic glycolysis, to generate ATP and induce the expression of factors that increase the supply of oxygen and nutrients. Strikingly, low oxygen conditions (hypoxia) and inflammatory signals share selected transcriptional events, including the activation of members of both the hypoxia-inducible factor and nuclear factor κB families, which may converge to activate specific cell programs. In the pathological response to hypoxia, cancer in particular, macrophages act as orchestrators of disease evolution and their number can be used as a prognostic marker. Here we review mechanisms of macrophage adaptation to hypoxia, their role in disease as well as new perspectives for their therapeutic targeting.

Entities:  

Mesh:

Year:  2012        PMID: 23179187     DOI: 10.1093/intimm/dxs110

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  33 in total

1.  Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia.

Authors:  Lei-Lei Tao; Shu-Jing Shi; Long-Bang Chen; Gui-Chun Huang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

2.  IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies.

Authors:  Aimalie L Hardaway; Izabela Podgorski
Journal:  Future Med Chem       Date:  2013-06       Impact factor: 3.808

3.  NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.

Authors:  Jun Xu; Feng Chi; Tongsheng Guo; Vasu Punj; W N Paul Lee; Samuel W French; Hidekazu Tsukamoto
Journal:  J Clin Invest       Date:  2015-03-23       Impact factor: 14.808

4.  Lack of the Transcription Factor Hypoxia-Inducible Factor 1α (HIF-1α) in Macrophages Accelerates the Necrosis of Mycobacterium avium-Induced Granulomas.

Authors:  Marcos S Cardoso; Tânia M Silva; Mariana Resende; Rui Appelberg; Margarida Borges
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

5.  RhoB regulates the function of macrophages in the hypoxia-induced inflammatory response.

Authors:  Gaoxiang Huang; Jie Su; Mingzhuo Zhang; Yiduo Jin; Yan Wang; Peng Zhou; Jian Lu
Journal:  Cell Mol Immunol       Date:  2015-09-21       Impact factor: 11.530

6.  Macrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.

Authors:  Ivan Shabo; Hans Olsson; Rihab Elkarim; Xiao-Feng Sun; Joar Svanvik
Journal:  Cancer Microenviron       Date:  2014-04-28

7.  STAT4 contributes to adipose tissue inflammation and atherosclerosis.

Authors:  A D Dobrian; M A Hatcher; J J Brotman; E V Galkina; P Taghavie-Moghadam; H Pei; B A Haynes; J L Nadler
Journal:  J Endocrinol       Date:  2015-08-18       Impact factor: 4.286

Review 8.  Inflammatory Disequilibrium in Stroke.

Authors:  Danica Petrovic-Djergovic; Sascha N Goonewardena; David J Pinsky
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

Review 9.  Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.

Authors:  Marica Garziera; Giuseppe Toffoli
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

10.  Hypoxia-inducible transcription factors, HIF1A and HIF2A, increase in aging mucosal tissues.

Authors:  Jeffrey L Ebersole; Michael John Novak; Luis Orraca; Janis Martinez-Gonzalez; Sreenatha Kirakodu; Kuey C Chen; Arnold Stromberg; Octavio A Gonzalez
Journal:  Immunology       Date:  2018-02-14       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.